HAVCR2 and salivary gland carcinoma: These were the PD-1/PD-L1 interaction, that has already been evaluated in SDCs 16 and tested in advanced salivary gland carcinomas 14, as well as the CTLA-4/DC86 and TIM-3/galectin-9 interactions.